Illustration of coronavirus

Activity content starts in:

Industry Webcast

Clinical Trial Data and Real-World Evidence Behind an Oral Treatment Option for Adult Patients at High Risk for Progression to Severe COVID-19Industry Webcast Sponsored by Pfizer Inc.; Not for CME/CE Credit

Learn about clinical trial data and real-world evidence behind an oral treatment option for adults with COVID-19 at high risk for progression to severe illness. Additionally, we will discuss how to identify high-risk patients, tools and resources to manage potential DDIs, and more.

Register

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 1/15/2025

Expiration Date: 1/15/2025

Faculty

Faculty

Supporters and Partners

Industry Sponsor

Pfizer Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Clinical Trial Data and Real-World Evidence Behind an Oral Treatment Option for Adult Patients at High Risk for Progression to Severe COVID-19

Register